[{"indications": "Indications\u00a0myasthenia gravis", "name": "PYRIDOSTIGMINE BROMIDE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "10 Musculoskeletal and joint diseases", "10.2 Drugs used in neuromuscular disorders", "10.2.1 Drugs that enhance neuromuscular transmission", "Anticholinesterases", "PYRIDOSTIGMINE BROMIDE"], "cautions": "Cautions\u00a0see under Neostigmine; weaker muscarinic action", "side-effects": "Side-effects\u00a0see under Neostigmine", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/5332.htm", "doses": ["By mouth, 30\u2013120\u00a0mg at suitable intervals\r\nthroughout day, total daily dose 0.3\u20131.2\u00a0g (but see also notes above); child under 18 years, see BNF for Children"], "pregnancy": "Pregnancy\u00a0see under Neostigmine"}]